Nesvacumab
- Generic Name
- Nesvacumab
- Drug Type
- Biotech
- CAS Number
- 1296818-77-3
- Unique Ingredient Identifier
- WX8293WGLC
- Background
Nesvacumab is under investigation in clinical trial NCT01997164 (Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular (Wet) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath